Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185–90. , , , .
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295–306. , , , , , , , , , , , , , , .
Lupus anticoagulant (LA) testing: performance of clinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity. Clin Chem 2003; 49: 1608–14. , , , .
Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation. Thromb Haemost 1997; 77: 934–7. , , , , .
Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of the Australasia Quality Assurance Programs for Hematology. Semin Thromb Haemost 2005; 31: 49–58. , , , , , , , , , , .
Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I. Thromb Haemost 1999; 81: 929–34. , , .
on behalf of participating centers of Italian Federation of Thrombosis Centers (FCSA). Survey on lupus anticoagulant diagnosis by central evaluation of positive plasma samples. J Thromb Haemost 2007; 5: 925–30. , , , , , , , , , , , .
Clinical and Laboratory Standards Institute (CLSI). Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline – Fifth Edition. CLSI document H21-A5 (ISBN 1-56238-657-3). Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087–1898 USA, 2008.
Preanalytical variables in coagulation testing. Blood Coagul Fibrinolysis 2007; 18: 86–9. .
Kaolin clotting time and dilute Russell viper venom time distinguish between prothrombindependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies. Blood 1995; 86: 617–23. , , , .
Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. Blood Rev 2008; 2: 93–105. , , .
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers. Blood 2008; 112: 1687–95. , , , , , .
Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment: performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA. Thromb Haemost 2002; 88: 583–6. , , , .
A hexagonal (II) phase phospholipids neutralization assay for lupus anticoagulant identification. Thromb Haemost 1993; 70: 787–93. , , .
The Lupus Ratio test: an interlaboratory study on the detection of Lupus anticoagulants by an APTT-based, integrated, and semiquantitative test. Fifth International Survey of Lupus Anticoagulants ISLA 5. Thromb Haemost 2000; 83: 704–8. , , , , .
Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost 1987; 57: 144–7. , , , , .
The Textarin/Ecarin ratio: a confirmatory test for lupus anticoagulants. Thromb Haemost 1993; 70: 925–31. , , , .
The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants. Blood Coagul Fibrinolysis 2003; 14: 307–12. , , .
A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without. Arterioscler Thromb Vasc Biol 2007; 27: 309–10. , , , , , , , , .